CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will present a corporate overview at the Cowen and Company 29th Annual Health Care Conference on Wednesday, March 18, at 10:15 a.m. (ET) at the Boston Marriott Copley Place in Boston, MA.
